About

Executive Team

iNova is a leading independent, consumer healthcare company backed by private equity.

Our Executive Leadership Team pride themselves on their strong connection to our teams, our customers and our partners.

Working together, they are responsible for steering the company’s strategy, performance and culture now and into the future.

Shumit Kapoor

Chief Executive Officer

Shumit Kapoor is the CEO of iNova Pharmaceuticals and a member of the Board of Directors.

He joined iNova in 2026, bringing more than three decades of global executive experience across the consumer goods and technology sectors.

Prior to iNova, he held a number of senior executive positions at Kellanova, including President, Asia Pacific, Middle East and Africa (AMEA). As a member of Kellanova's Executive Committee, he played a key role in shaping business strategy across the region and served on the Boards of the company's Africa and China joint ventures.

Sacha Ernst

President AMENA

Sacha Ernst is President of iNova’s AMENA Region which includes Asia, Europe, Middle East & North Africa. 

Sacha first joined iNova in 2018. He has over 25 years’ of international healthcare industry experience across finance, corporate strategy, business development and general management. Prior to joining iNova Sacha has held several senior roles spanning Asia, Europe and USA in multi-national companies including DKSH and Novartis.

Andrew Jenkin

President, CANZ & South Africa

Andrew Jenkin is the President of iNova’s CANZ (Canada, Australia and New Zealand) & South Africa regions. He holds the role of Director and Deputy Chairperson on the Board of Consumer Healthcare Products Australia (CHPA).

Andrew first joined iNova in 2019. He has over 25 years of experience in senior leadership roles across both consumer health and prescription categories in multi-national pharmaceutical companies including Pfizer, Bayer, MSD and Novartis.

Kym Hampton

Global Head of Medical Affairs and Professional Channels

Kym Hampton is the Global Head of Medical Affairs and Professional Channels of iNova Pharmaceuticals.
 
Kym joined iNova in 2013. She has over 25 years of healthcare industry experience including senior leadership positions in multi-national healthcare companies in South Africa including Adcock Ingram among others.

Paul Smith

Chief Operating Officer

Paul joined iNova in May 2022. He has over 25 years of experience in operational, strategic and leadership roles for pharmaceutical and consumer healthcare business units within multinational pharmaceutical company GSK/Haleon. Paul holds an MBA from Imperial College London, and a BSc in Environmental Chemistry.

Yee Leng Goh

Chief People Officer

Yee Leng joined iNova in 2024. She is a dynamic leader with over 25 years of HR experience across a broad range of industries including pharmaceutical, healthcare, banking and technology. Prior to joining iNova, Yee Leng held senior global and regional leadership roles in a number of multinational companies including ASM International, Allergan, DBS Bank and Nokia Siemens among others.

William Foo

Chief Financial Officer

William joined iNova in 2024. He has over 20 years of global financial experience, many of which were at private equity portfolio companies. Prior to joining iNova, William held senior financial leadership roles in multi-national FMCG and professional service companies including LUXASIA, Everise and Knowledge Universe. William is a Chartered Accountant of Singapore.

Filomena Maiese 

Chief Global Brands & Innovation Officer

Filomena joined iNova in 2018 as Global head of portfolio strategy and innovation. She brings with her more than 25 years of experience in leadership roles across multinational consumer healthcare organisations including Pfizer Consumer and Johnson & Johnson Consumer (Kenvue). Filomena has a track record of success in building iconic brands and product pipeline across markets for major consumer health brands.

Kate Messiter

General Counsel and Head of Communications

Kate joined iNova in 2017. She has over 20 years of experience leading legal teams in the healthcare media industries. Immediately prior to joining iNova, Kate held the role of Company Secretary and Head of Legal & Compliance for Mundipharma ANZ. Prior to that role, Kate held senior legal roles at Novartis, Fairfax and was a lawyer at Mallesons.

Luke Marsden

Vice President & Global Head of M&A / Business Development

Luke joined iNova in 2023. He has over 20 years of experience in corporate finance and mergers and acquisitions. Prior to joining iNova Luke held a number of senior leadership roles specialising in the consumer, retail and healthcare sectors facilitating multi-national transactions across Asia Pacific, Europe and the US.

Brands & Products